Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - Latest https://ift.tt/3nX8fwP
via
Subscribe to:
Post Comments (Atom)
-
from NDTV News - Special https://ift.tt/3fVexf6 via
-
Telangana Govt Jobs – Government Jobs in Telangana Get latest Telangana Govt Jobs 2017 here. This is the Page where you can ge...
-
The railways on Wednesday said bookings for 200 regular passenger trains will open from 10 am tomorrow on the IRCTC website or through its a...
Lower Entry Barriers After Record Antitrust Fine: Alibaba As Shares Rally
Alibaba Group CEO Daniel Zhang said on Monday he does not expect any material impact from the change of exclusivity arrangement imposed by C...
No comments:
Post a Comment